Peter J Quesenberry
Overview
Explore the profile of Peter J Quesenberry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
2614
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quesenberry P, Wen S, Goldberg L, Dooner M
Leukemia
. 2022 Oct;
36(12):2784-2792.
PMID: 36307485
Current dogma is that there exists a hematopoietic pluripotent stem cell, resident in the marrow, which is quiescent, but with tremendous proliferative and differentiative potential. Furthermore, the hematopoietic system is...
2.
Goldberg L, Dooner M, Papa E, Pereira M, Del Tatto M, Cheng Y, et al.
Stem Cell Rev Rep
. 2022 May;
18(7):2351-2364.
PMID: 35503199
Hematopoietic stem cells express differentiation markers B220 and Gr1 and are proliferative. We have shown that the expression of these entities changes with cell cycle passage. Overall, we conclude that...
3.
Jeong E, Pereira M, So E, Wu K, Del Tatto M, Wen S, et al.
Cardiovasc Res
. 2022 Jan;
118(16):3211-3224.
PMID: 35018410
Aims: Pulmonary arterial hypertension (PAH) is a fatal disease without a cure. Previously, we found that transcription factor RUNX1-dependent haematopoietic transformation of endothelial progenitor cells may contribute to the pathogenesis...
4.
Klinger J, Pereira M, Del Tatto M, Dooner M, Wen S, Quesenberry P, et al.
Pulm Circ
. 2022 Jan;
11(4):20458940211046137.
PMID: 34987768
Rationale: Mesenchymal stem cell extracellular vesicles (MSC EVs) reverse pulmonary hypertension, but little information is available regarding what dose is effective and how often it needs to be given. This...
5.
So E, Jeong E, Wu K, Dubielecka P, Reginato A, Quesenberry P, et al.
Aging (Albany NY)
. 2020 Dec;
12(24):25939-25955.
PMID: 33378745
Adult hematopoietic stem and progenitor cells (HSPCs) reside in the bone marrow (BM) ensuring homeostasis of blood production and immune response throughout life. Sex differences in immunocompetence and mortality are...
6.
Wang L, Moore D, Huang J, Wang Y, Zhao H, D-H Yue J, et al.
FASEB J
. 2020 Nov;
35(1):e21106.
PMID: 33165997
The protein tyrosine phosphatase SHP2, encoded by PTPN11, is ubiquitously expressed and essential for the development and/or maintenance of multiple tissues and organs. SHP2 is involved in gastrointestinal (GI) epithelium...
7.
Baumgartner A, Quesenberry P
J Hematol
. 2020 Apr;
6(1):21-24.
PMID: 32300387
Hereditary coproporphyria (HCP) is the third most common of the acute porphyrias, after acute intermittent porphyria and variegate porphyria. It is caused by decreased activity of the sixth step in...
8.
Kholia S, Herrera Sanchez M, Cedrino M, Papadimitriou E, Tapparo M, Deregibus M, et al.
Front Cell Dev Biol
. 2020 Apr;
8:188.
PMID: 32266268
Limitations in the current therapeutic strategies for the prevention of progression of chronic kidney disease (CKD) to end stage renal disease has been a drawback to improving patient recovery. It...
9.
Ventetuolo C, Aliotta J, Braza J, Chichger H, Dooner M, McGuirl D, et al.
Eur Respir J
. 2020 Jan;
55(3).
PMID: 31949110
Endothelial dysfunction is a hallmark of pulmonary arterial hypertension (PAH) but there are no established methods to study pulmonary artery endothelial cells (PAECs) from living patients. We sought to culture...
10.
Klinger J, Pereira M, Del Tatto M, Brodsky A, Wu K, Dooner M, et al.
Am J Respir Cell Mol Biol
. 2019 Nov;
62(5):577-587.
PMID: 31721618
Mesenchymal stem cell extracellular vesicles attenuate pulmonary hypertension, but their ability to reverse established disease in larger animal models and the duration and mechanism(s) of their effect are unknown. We...